June 10, 2021
Over the past decade, single arm trials have emerged as an accepted way of assessing a new treatment intervention...
February 12, 2021
In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..
December 21, 2020
2020 has been an unusually difficult year as the global pandemic impacted all of our lives. This year, the Cytel blog..
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his..
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic..
October 13, 2020
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for..
October 7, 2020
With the rise in digital technologies, there has been an explosion in the volume and type of data sources. We can..
September 25, 2020
Regulators in both the United States and Europe have responded positively to the use of synthetic control arms (SCA)s..